REPL vs SLB
Replimune Group Inc (REPL) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
REPL does not have a complete income-statement cache yet.
Latest reported SLB revenue for 2025-12-31 was $35.71B. Net income was $3.37B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
REPL currently screens at market cap $825.7M. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the REPL and SLB stock pages for the full models.
Not investment advice.